group, the FLASH (Follicular Lymphoma Analysis of Surrogacy Hypothesis)
Mayo Clinic
No affiliation available
Citations 1
Evaluation of complete response rate at 30 months (CR30) as a surrogate for progression-free survival (PFS) in first-line follicular lymphoma (FL) studies: Results from the prospectively specified Follicular Lymphoma Analysis of Surrogacy Hypothesis (FLASH